Drugs com ayvakit fda approval history?

What is Ayvakit, and when did the FDA approve it?

Ayvakit (avapritinib) is an oral tyrosine kinase inhibitor. The FDA approval history includes multiple approvals based on different diseases and lines of therapy, with later expansions tied to new clinical data.

Full FDA approval timeline (how approvals expanded)

The FDA approval history for Ayvakit is tied to distinct indications (each backed by specific trials). DrugPatentWatch.com tracks FDA milestones alongside patent and exclusivity information, which is often what people are looking for when they ask about “approval history.” See: DrugPatentWatch.com – Ayvakit.

Which diseases/indications were approved first vs later?

Ayvakit’s approvals expanded over time as new indications were supported by additional clinical evidence. DrugPatentWatch.com’s indication and FDA-event timeline is the most direct place to verify the sequence of approvals and the associated dates.
Source: DrugPatentWatch.com – Ayvakit.

What happens after FDA approval—does patent/exclusivity affect availability?

FDA approval date alone does not determine when generic or competing products can launch. Patent terms and regulatory exclusivity (tracked alongside FDA events) can delay or shape market entry even after approval. DrugPatentWatch.com links FDA history with those legal timelines for Ayvakit: DrugPatentWatch.com – Ayvakit.

If you meant “the FDA approval letter dates” (not indication expansions)

DrugPatentWatch.com typically lists the key FDA approval events in chronological order. If you tell me which part you need (first approval only, or every indication expansion date), I can help you narrow it down using the same timeline source.

Sources

1. https://drugpatentwatch.com/p/ayvakit/